1-3 of 3
Rahul Lakhotia
Close
Sort by
Journal Articles

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R

Clinical Trials & Observations
Rahul Lakhotia, Kieron Dunleavy, Jeremy S. Abramson, Brian K. Link, Bayard L. Powell, Christopher Melani, Andrea N. Lucas, Seth M. Steinberg, Jonathan W. Friedberg, Brad S. Kahl, Richard F. Little, Nancy L. Bartlett, Ariela Noy, Wyndham H. Wilson, Mark Roschewski
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5320–5324.
https://doi.org/10.1182/bloodadvances.2023010223
Published: 2023
Journal Articles

Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma

Clinical Trials & Observations
Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, Stefania Pittaluga, Nakhle Saba, Liza Lindenberg, Esther Mena, Ethan Bergvall, Andrea Nicole Lucas, Allison Jacob, Erik Yusko, Seth M. Steinberg, Elaine S. Jaffe, Adrian Wiestner, Wyndham H. Wilson, Mark Roschewski
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2667–2680.
https://doi.org/10.1182/bloodadvances.2021006397
Published: 2022
Includes: Supplemental data
Journal Articles

Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL

Clinical Trials & Observations
Milos D. Miljkovic, Christopher Melani, Stefania Pittaluga, Rahul Lakhotia, Nicole Lucas, Allison Jacob, Erik Yusko, Elaine S. Jaffe, Wyndham H. Wilson, Mark Roschewski
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4198–4210.
https://doi.org/10.1182/bloodadvances.2020003679
Published: 2021
Includes: Supplemental data